Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PEMDAC: Pembrolizumab and Entinostat in Metastatic Uveal Melanoma
NCT02697630Phase 2Completed
- Sponsor
- Region Västra Götaland
- Start
- Feb 2018
- Primary completion
- Jan 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of entinostat in Uveal melanoma (UM), sponsored by Region Västra Götaland. Started Feb 2018; status: completed.
02
Drugs
entinostat
03
Conditions
Uveal melanoma (UM)
Beyond the preview
Go deeper on NCT02697630.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02697630.